20733125

Source:http://linkedlifedata.com/resource/pubmed/id/20733125

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019618, umls-concept:C0871261, umls-concept:C0939537, umls-concept:C0994524, umls-concept:C1527017, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	31
pubmed:dateCreated	2010-10-29
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/ARG tyrosine kinase, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-kit, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Platelet-Derived Growth..., http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Platelet-Derived Growth..., http://linkedlifedata.com/resource/pubmed/chemical/imatinib
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1527-7755
pubmed:author	pubmed-author:AminHesham MHM, pubmed-author:Garrido-LagunaIgnacioI, pubmed-author:JankuFilipF, pubmed-author:KurzrockRazelleR, pubmed-author:TrentJonathan CJC, pubmed-author:YangDanD
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	28
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	e633-6
pubmed:meshHeading	pubmed-meshheading:20733125-Administration, Oral, pubmed-meshheading:20733125-Adult, pubmed-meshheading:20733125-Aged, pubmed-meshheading:20733125-Antineoplastic Agents, pubmed-meshheading:20733125-Brain Neoplasms, pubmed-meshheading:20733125-Diagnosis, Differential, pubmed-meshheading:20733125-Drug Administration Schedule, pubmed-meshheading:20733125-Erdheim-Chester Disease, pubmed-meshheading:20733125-Female, pubmed-meshheading:20733125-Genes, abl, pubmed-meshheading:20733125-Histiocytosis, Langerhans-Cell, pubmed-meshheading:20733125-Humans, pubmed-meshheading:20733125-Lung Neoplasms, pubmed-meshheading:20733125-Male, pubmed-meshheading:20733125-Middle Aged, pubmed-meshheading:20733125-Mutation, pubmed-meshheading:20733125-Piperazines, pubmed-meshheading:20733125-Positron-Emission Tomography, pubmed-meshheading:20733125-Protein Kinase Inhibitors, pubmed-meshheading:20733125-Protein-Tyrosine Kinases, pubmed-meshheading:20733125-Proto-Oncogene Proteins c-kit, pubmed-meshheading:20733125-Pyrimidines, pubmed-meshheading:20733125-Receptor, Platelet-Derived Growth Factor alpha, pubmed-meshheading:20733125-Receptor, Platelet-Derived Growth Factor beta, pubmed-meshheading:20733125-Remission Induction, pubmed-meshheading:20733125-Tomography, X-Ray Computed, pubmed-meshheading:20733125-Treatment Outcome
pubmed:year	2010
pubmed:articleTitle	Response of histiocytoses to imatinib mesylate: fire to ashes.
pubmed:affiliation	The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
pubmed:publicationType	Journal Article, Case Reports